Cellectar Biosciences (CLRB) Announces 7.03M Share Offering by Selling Stockholders
- Wall Street mixed; Dow pressured by selloff in Salesforce shares
- S&P 500 to re-test lows in H1 and then rally to 4200 on Fed pivot signal - JPMorgan
- Salesforce (CRM) drops after soft results, MS sees attractive valuation
- Snowflake (SNOW) falls as macro headwinds drag on guidance, analysts remain upbeat
- Piper Sandler says Apple (AAPL) likely lost 9M iPhone 14 units, cuts revenue estimates
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Cellectar Biosciences (NASDAQ: CLRB) has filed for up to 7,027,043 share offering by selling stockholders. Shares are issuable upon exercise of warrants.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top Ships (TOPS) plans offer of common stock, warrants
- FREYR Battery (FREY) Prices Upsized $230M Public Offering of Ordinary Shares at $11.50/sh
- NaaS Technology (NAAS) Announces $30 Million Private Placement of Ordinary Shares
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!